Invacare Co. (NYSE:IVC) Chairman Matthew E. Monaghan bought 13,750 shares of the company’s stock in a transaction dated Thursday, November 8th. The stock was purchased at an average price of $7.26 per share, with a total value of $99,825.00. Following the completion of the transaction, the chairman now directly owns 243,897 shares in the company, valued at approximately $1,770,692.22. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of Invacare stock traded down $0.10 during midday trading on Monday, hitting $5.40. 698,800 shares of the company traded hands, compared to its average volume of 462,171. The firm has a market capitalization of $182.60 million, a PE ratio of -2.81 and a beta of 1.96. The company has a current ratio of 2.05, a quick ratio of 1.34 and a debt-to-equity ratio of 0.68. Invacare Co. has a 12 month low of $5.31 and a 12 month high of $20.00.
Invacare (NYSE:IVC) last announced its quarterly earnings results on Monday, November 5th. The health services provider reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.10). The company had revenue of $244.60 million for the quarter, compared to the consensus estimate of $250.59 million. Invacare had a negative net margin of 6.17% and a negative return on equity of 12.98%. The company’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period last year, the firm posted ($0.41) earnings per share. As a group, research analysts anticipate that Invacare Co. will post -1.55 earnings per share for the current year.
Institutional investors and hedge funds have recently bought and sold shares of the business. Bank of Montreal Can grew its holdings in Invacare by 7,076.0% during the 2nd quarter. Bank of Montreal Can now owns 7,463 shares of the health services provider’s stock worth $139,000 after acquiring an additional 7,359 shares during the last quarter. Piedmont Investment Advisors LLC bought a new stake in Invacare during the 2nd quarter worth approximately $144,000. Contravisory Investment Management Inc. bought a new stake in Invacare during the 2nd quarter worth approximately $159,000. Trexquant Investment LP bought a new stake in Invacare during the 3rd quarter worth approximately $148,000. Finally, Brown Advisory Inc. bought a new stake in Invacare during the 2nd quarter worth approximately $207,000.
Several brokerages recently issued reports on IVC. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a report on Wednesday, October 17th. ValuEngine raised shares of Invacare from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Finally, TheStreet lowered shares of Invacare from a “c” rating to a “d+” rating in a report on Friday, August 10th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $21.50.
TRADEMARK VIOLATION WARNING: This piece of content was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2018/12/03/matthew-e-monaghan-purchases-13750-shares-of-invacare-co-ivc-stock.html.
Invacare Company Profile
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific.
Recommended Story: Trading Strategy
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.